Stent Thrombosis With Everolimus-Eluting Stents | Zendy

Tullio Palmerini | Zendy; Ajay J. Kirtane | Zendy; Patrick W. Serruys | Zendy; Pieter C. Smits | Zendy; Elvin Kedhi | Zendy; Dean J. Kereiakes | Zendy; Diego Sangiorgi | Zendy; Maria Letizia Bacchi Reggiani | Zendy; Christoph Kaiser | Zendy; HyoSoo Kim | Zendy; Antoinette de Waha | Zendy; Flavio Ribichini | Zendy; Gregg W. Stone | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Stent Thrombosis With Everolimus-Eluting Stents

Author(s) -

Tullio Palmerini,

Ajay J. Kirtane,

Patrick W. Serruys,

Pieter C. Smits,

Elvin Kedhi,

Dean J. Kereiakes,

Diego Sangiorgi,

Maria Letizia Bacchi Reggiani,

Christoph Kaiser,

HyoSoo Kim,

Antoinette de Waha,

Flavio Ribichini,

Gregg W. Stone

Publication year - 2012

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.111.967083

Subject(s) - medicine , randomized controlled trial , relative risk , stent , meta analysis , surgery , confidence interval

Some but not all studies have reported reduced rates of stent thrombosis (ST) with everolimus-eluting stents (EES) compared with other drug-eluting stents (DES). All of these studies were insufficiently powered to reliably detect differences in ST. We therefore performed a meta-analysis of randomized controlled trials comparing the risk of 2-year definite ST between EES and other DES.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research